skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin

Review

(2328) Views  (585) Full article downloads

Authors: Anbu Pandian, Anjali Arora, Laurence S Sperling, Bobby V Khan

Published Date August 2008 Volume 2008:4(5) Pages 1001 - 1009
DOI: http://dx.doi.org/10.2147/VHRM.S3460

Anbu Pandian1, Anjali Arora2, Laurence S Sperling1, Bobby V Khan1

1Emory University School of Medicine and Grady Memorial Hospital Vascular Research Atlanta, Georgia USA; 2Sir Ganga Ram Hospital, New Delhi, India

Abstract: Dyslipidemia is a major risk factor in the initiation and progression of cardiovascular diseases such as atherosclerosis. Several pharmacological agents have been developed over the past 50 years which target various lipid components such as low density lipoprotein (LDL) cholesterol, triglyceride, and high density lipoprotein (HDL) cholesterol. Similar to other risk factors such as hypertension and diabetes mellitus, the management of dyslipidemia can be complicated and may require combination therapy for effective treatment. This review discusses the biochemical mechanisms of action and clinical uses for simvastatin (the most widely available and commercially prescribed statin) and niacin, and the combination of these agents in the management and treatment of dyslipidemia.

Keywords: dyslipidemia, HDL cholesterol, triglyceride, statin, niacin








Readers of this article also read:

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
Under- and overreporting of energy in a group of candidates for CABG surgery and its association with some anthropometric and sociodemographic factors, Tehran, Iran
Arterial pulmonary hypertension in noncardiac intensive care unit
Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study
Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Erratum
A case of recurrent bloody tears
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University